The Front Room — a clinical regulatory commons
RSS
← Back to feed

Sedana Medical NDA accepted for FDA review

Sponsor
Sedana Medical AB
Drug
Sedaconda · isoflurane
Indication
ICU sedation of mechanically ventilated adult patients
More on Sedana Medical AB ↗ Google News

FDA accepted Sedana Medical's NDA for isoflurane inhalation delivered via the Sedaconda ACD device for ICU sedation of mechanically ventilated adults.

What this means

Isoflurane is an inhaled anaesthetic long used in operating rooms in the US. Sedana Medical's application asks the FDA to approve isoflurane, delivered through the Sedaconda ACD device at the ICU bedside, for sedating adults on mechanical ventilators. FDA acceptance starts the formal review clock. If approved, inhaled isoflurane would offer US ICUs a new sedation modality alongside the intravenous drugs propofol and midazolam.

Read original at news.google.com ↗
Topic ICU sedation

Drug Watch — recent news on Sedaconda